Abattis Biologix Prepares for the Launch of its First High Value Product…
Nitric Oxide (NO)
Abattis Biologix CNSX:FLU $0.05 is preparing to launch the first of several high value products in June of this year. Over the past few months, Abattis has contacted key distributors asking which high value/margin products in Abattis pipeline that the distributors want. Aside from any and all krill oil products and blends, Nitric Oxide is the predominant product that distributors are keen on. It is a product that attracts high margins, is in high demand and has the potential for several high value orders in excess of $100,000 dollars. Nitric Oxide (NO) has little, if any market penetration in Canada. The product is sold in nutrition stores as a workout supplement and not as a natural cardiovascular system regulator targeted at Baby Boomers. The team at Abattis plans on filling this niche market.
Biotechs are the next big supercycle. North America’s largest demographic (baby boomers) are set to drive demand in this sector for the next 20 years. Financial pressures, quality of life issues and fear of being left with significant uncovered medical expenses later in life are driving this massive market segment into natural health products. Products such as Krill Oil, Acai, Nitric Oxide, are at the heart of what is driving prevention medicine. Boomers are driving the natural health craze and are intent on preventing a wide variety of health issues. The one major issue that tops all others in the health care industry is cardiovascular and heart health. This market segment costs the global economy almost a trillion dollars in direct and indirect costs per year with that figure standing at $863B in 2010.
Abattis first high value product launch is targeting this lucrative industry
Nitric Oxide tablets fill this underserved $863B niche market.
The Nobel Prize winning discovery of 1998 Nitric Oxide is finally hitting the shelves in Canada in summer of 2012. It is already available in Canada as a workout supplement drink, but has yet to hit the shelves designed for one of the biggest sectors in medicine, cardiovascular and heart health. At over $860B in costs related to heart disease, there is a huge market for health products that prevent this disease. The one product at the cutting edge of science and medicine is the Nobel Prize winning Nitric Oxide. Nitric Oxide helps replenish vital NO levels in the Endothelial System which is responsible for maintaining a healthy cardiovascular system and ultimately leading to heart issues. NO has been found to lower blood pressure, significantly reduce triglycerides and increase important nitrates and plasma nitrates in the body.
Nitric Oxide is a product that will become very popular among aging baby boomers looking to prevent all sorts of heart disease including heart attacks and strokes. Nitric Oxide is a natural compound that will play a vital role maintain the cardiovascular system and preventing a wide variety of heart disease which will dramatically reduce diagnostic and treatment costs in this specific area of medicine regarding cardiovascular and heart health.
When it comes to heart health, never has the saying “An ounce of prevention is worth a pound the cure” been more true. In this case, not having the cure is the best medicine of all considering have a heart attack or stroke will change your life instantly virtually guaranteeing a loss of quality of life for any sufferer of such condition.
The American Heart Association says…
“The discovery of nitric oxide and its function is one of the most important in the history of cardiovascular medicine.”
That is the American Heart Association saying this, if the AHA is bold enough to make these claims about Nitric Oxide then I have full confidence that NO will play a vital role in 21st century medicine. The AHA is one of the most reputable non biased medical establishments anywhere in the world and if they believe that Nitric Oxide is that revolutionary for heart health, who am I to argue? Nitric Oxide according to Dr. Tim Fealey is a company maker in itself. When talking with Mike and Tim at the Wellness Show a few weeks prior, Mike queried Tim about which product in Abattis extensive product pipeline had the most potential.
Without hesitation, Tim singled out Nitric Oxide.
Abattis’ Nitric Oxide… First Mover Status in Canada
Nitric Oxide has distribution as a workout supplement, but is not marketed in Canada as a natural way at improving and regulating cardiovascular/heart health. Abattis Nitric Oxide product focuses on this specific market segment. The market for a product like NO is massive and has the potential in itself to produce multimillion dollar revenue streams for the company within a few short years. The specific market segment for NO is 45 years and over which is half the population in Canada. This gives Abattis a very large and underserved market within Canada to target. Abattis plans on delivering its first Nitric Oxide products in Canada in June. This is a big win for Mike and the gang at Abattis as the product launch, expected to bring at least a quarter of a million dollars revenue in the first year under conservative estimates. Sales of the NO product will top $5M within 5 years of the product launch.
Abattis has first mover status in Canada which will guarantee their NO product attracts premium shelf placement, premium pricing, and brand recognition as a first mover. If Tim Fealey says Nitric Oxide is the company and the American Heart Association says it’s the biggest thing to happen to heart medicine ever, NO is a natural compound that will have dramatic effects on reducing costs associated with treating heart disease making this one market and its product… the biggest potential market in any segment of health and medicine. Abattis Biologix is truly sitting on billion dollar potential. |
